Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|February 1, 1990
Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)T De Witte, F Zwaan, J Hermans, et al.
Klinische Wochenschrift|June 18, 1985
Bone marrow transplantation for chronic granulocytic leukaemiaH K Mahmoud, U W Schaefer, F Schüning, et al.
Bone Marrow Transplantation|September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 yearsG Andreola, M Labopin, D Beelen, et al.
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
Journal of Hematology & Oncology|January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemiaSimona Piemontese, F Ciceri, M Labopin, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Annals of Hematology|September 22, 2016
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMTE M P Cremers, A van Biezen, L C de Wreede, et al.
Journal of Internal Medicine|October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?O Ringdén, M Labopin, B Sadeghi, et al.
Bone Marrow Transplantation|September 15, 2015
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)N Kröger, M Bornhäuser, M Stelljes, et al.
Pageof 4